====== BioProtection Systems ======

{{ :pharmaceutical_companies:bioprotection_systems.png?200|}}

**BioProtection Systems Corporation (BPSC)** was an American biotechnology company based in [[united_states:iowa:Ames]], [[united_states:Iowa]].((//Home.// BioProtection Systems. Retrieved April 10, 2010, from https://web.archive.org/web/20100410020449/http://www.bpsys.net/))

===== History =====

==== Founding ====

BPSC was founded in 2005 as a subsidiary of [[NewLink Genetics]].((//Home.// BioProtection Systems. Retrieved April 10, 2010, from https://web.archive.org/web/20100410020449/http://www.bpsys.net/))

==== Ebola ====

On August 5, 2014, BPSC announced that it had received an initial $1 million contract from the [[:Defense Threat Reduction Agency]] (DTRA) to bring the [[:rVSV-ZEBOV-G]] vaccine candidate against [[:Ebola]] to clinical trials. The candidate was licensed from the [[:Public Health Agency of Canada]] (PHAC).((Link, G. (2014, August 5). //NewLink Genetics Corporation, Through Its Wholly Owned Subsidiary, BioProtection Systems Corporation, Secures a Letter Contract From the Defense Threat Reduction Agency for Testing and Evaluation of Ebola Virus Vaccine.// Lumos Pharma. https://archive.ph/kNgC6)) Dr. [[:Robert Malone]] was tapped by the DTRA to lead the program.((//The Team.// Atheric Pharmaceutical. Retrieved July 14, 2017, from https://web.archive.org/web/20170714055404/http://www.atheric.com/team)) ((Malone, R. W. (2017, March). //RWM CV.// Squarespace. https://web.archive.org/web/20230119104151/https://static1.squarespace.com/static/550b0ac4e4b0c16cdea1b084/t/58e5406b5016e1f1acacae75/1491419246742/RWM+CV+March+2017.pdf))